Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Magnetic Resonance in Medicine|January 1, 1991
Phosphonate-modified GdDTPA complexes. I. NMRD study of the solution behavior of new tissue-specific contrast agentsI K Adzamli, M BlauInvestigative Radiology|February 1, 1991
Phosphonate-modified GdDTPA complexes. II. Evaluation in a rat myocardial infarct modelI K Adzamli, D Johnson, M BlauJournal of Magnetic Resonance Imaging : JMRI|November 1, 1993
Gadolinium phosphonates as MR imaging contrast agents: physiologic effects in rabbit heartsI K Adzamli, H Weinstein, J A LeppoInvestigative Radiology|June 1, 1994
Macromolecular infarct-specific magnetic resonance contrast agentsK Adzamli, H Mei, J A LeppoMagma (New York, N.Y.)|June 8, 2001
Deuterium NMR study of the MP-2269: albumin interaction--a step forward to the dynamics of non-covalent bindingK Adzamli, L Vander Elst, S Laurent, et al.Investigative Radiology|June 3, 1999
NMRD assessment of Gd-DTPA-bis(methoxyethylamide), (Gd-DTPA-BMEA), a nonionic MRI agentK Adzamli, M P Periasamy, M Spiller, et al.Journal of Medicinal Chemistry|January 1, 1989
Development of phosphonate derivatives of gadolinium chelates for NMR imaging of calcified soft tissuesI K Adzamli, H Gries, D Johnson, et al.The Biochemical Journal|June 1, 1982
Neutral complexes as oxidants for the reduced form of parsley (Petroselinum crispum) [2Fe--2S] ferredoxin. Evidence for partial blocking by redox-inactive Cr(III) complexesI K Adzamli, H O Kim, A G SykesInvestigative Radiology|December 16, 1998
Polyethyleneglycol-stabilized manganese-substituted hydroxylapatite as a potential contrast agent for magnetic resonance imaging: particle stability in biologic fluidsS Fallis, J Beaty-Nosco, R B Dorshow, et al.Journal of Inorganic Biochemistry|July 1, 1987
Kinetics of Pseudomonas aeruginosa cytochrome c551 and cytochrome oxidase oxidation by Co(phen)3(3+) and Mn(CyDTA)(H2O)-M G Tordi, M C Silvestrini, K Adzamli, et al.Pageof 3